InsiderTrades

AVTX Avalo Therapeutics, Inc.

Nasdaq · SEC CIK 1534120 · EDGAR

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$8.50M
23 sales by 6 insiders
Filings on record
184
since 2021-07-02, latest 2026-09-18 16:10
Buying vs selling by month open-market trades, last 24 months
BoughtSold

Most active insiders, 12 months

InsiderTitleBoughtSold
Sullivan Christopher RyanCFO —$3.72M
Doyle MittieChief Medical Off —$2.98M
VARKI PAULCLO —$1.51M
Goldman JonathanDir —$163.0K
Chan MitchellDir —$72.5K
Riley JenniferChief Strategy Off —$52.0K
Truex SamanthaDir ——
KANTOFF AARONDir ——
NEIL GARRY ARTHURCEO, Dir ——
KAPLAN GILLADir ——

Transactions 111

Type
Reset
X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2022-01-20 2022-01-18+ AVTX ARMISTICE CAPITAL, LLC Dir, 10% P - Purchase $0.8788 +312.0K 46.40M +0.7% +$274.2K
MI 2022-01-14 2022-01-12+ AVTX Boyd Steven Dir, 10% P - Purchase $0.992 +455.0K 46.10M +1.0% +$451.3K
MI 2022-01-11 2022-01-07+ AVTX Armistice Capital Master Fund Ltd. Dir, 10% P - Purchase $0.9999 +645.0K 45.63M +1% +$645.0K
2021-12-14 2021-12-10 AVTX Wilkins H Jeffrey Chief Medical Off P - Purchase $1.57 +6,371 33.4K +24% +$10.0K
2021-12-14 2021-12-10 AVTX Greenway Schond L. CFO P - Purchase $1.57 +2,231 3,883 +135% +$3,503
2021-12-14 2021-12-10 AVTX NEIL GARRY ARTHUR CSO P - Purchase $1.57 +4,267 85.6K +5% +$6,699
2021-12-14 2021-12-10 AVTX Harrell James Archie Jr Chief Commercial Off P - Purchase $1.57 +1,093 36.8K +3% +$1,716
2021-12-14 2021-12-10 AVTX Sullivan Christopher Ryan CAO P - Purchase $1.57 +955 9,004 +12% +$1,499
MI 2021-09-17 2021-09-15+ AVTX ARMISTICE CAPITAL, LLC Dir, 10% P - Purchase $2.20 +5.70M 45.00M +15% +$12.56M
MI 2021-08-18 2021-08-16+ AVTX Boyd Steven Dir, 10% P - Purchase $2.76 +50.0K 39.30M +0.1% +$138.1K
MI 2021-08-06 2021-08-04+ AVTX ARMISTICE CAPITAL, LLC Dir, 10% P - Purchase $2.73 +150.0K 39.20M +0.4% +$409.0K

Purchase Sale Sale after option exercise All abbreviations